Última actualização :
05/12/2025
Infostab
Lista de compostos
Listas de leitura dos resumos de informação
Pesquise compatibilidades
Tabela de compatibilidade do site Y
Bibliografía
As equipas de investigação
valistab
poster
Conexões
patrocinadores
Autores
Manual do utilizador
Boletim de notícias
Buscar
Cyclophosphamide
Cyclophosphamide
(Gran-bretanha, Estados Unidos de América, Arábia Saudita, nova Zelândia)
ATC :
L01AA01
Cyclophosphamide
ATC :
L01AA01
Cyclophosphamide
ATC :
L01AA01
40
Pharm Sci Communications
Stability and compatibility studies of four cytostatic agents (fluorouracil, dacarbazine, cyclophosphamide and ifosfamide) with PVC infusion bags.
50
Am J Health-Syst Pharm
Stability of ondansetron hydrochloride and cyclophosphamide in injectable solutions.
170
Am J Hosp Pharm
Effect of briefly heating cyclophosphamide solutions.
172
J Parenter Sci Technol
Chemical stability of two sterile, parenteral formulations of cyclophosphamide (Endoxan) after reconstitution and dilution in commonly used infusion fluids.
1728
Pharmazie
Stability of cyclophosphamide containing infusions.
1833
Ann Pharmacotherapy
Stability of cyclophosphamide and mesna admixtures in polyethylene infusion bags.
2000
J Pharm Biomed Anal
Quality control and stability study using HPTLC: applications to cyclophosphamide in various pharmaceutical products.
2016
Am J Health-Syst Pharm
Compatibility of palonosetron with cyclophosphamide and with ifosfamide during Y-site administration.
3096
Ann Pharmacotherapy
Stability of Cyclophosphamide in Extemporaneous Oral Suspensions.
4865
Dr REDDY laboratoire
Cyclophosphamide REDDY PHARMA 2000 mg/4 ML, solution à diluer pour solution injectable/perfusion. - Résumé des caractéristiques du produit.
4989
Dr REDDY
Extended dilution stability study report of cyclophosphamide concentrate for solution for infusion at room temperature and refrigerated condition ( 2-8°C) - Personal communication - July 2025
Mentions Légales
Buscar
